PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF NONPEPTIDIC HIV PROTEASE INHIBITORS

被引：0
|
作者：
GAJDA, C [1 ]
DOMAGALA, J [1 ]
TAIT, B [1 ]
HAGEN, S [1 ]
TUMINO, P [1 ]
FERGUSON, D [1 ]
PAVLOVSKY, A [1 ]
RUBIN, J [1 ]
LUNNEY, E [1 ]
机构：
[1] PARKE DAVIS PHARMACEUT RES,ANN ARBOR,MI 48105
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1995年 / 210卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：21 / MEDI
相关论文
共 50 条
  • [1] PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF NONPEPTIDIC HIV PROTEASE INHIBITORS
    TATLOCK, JH
    KALISH, VJ
    DAVIES, J
    APPELT, K
    REICH, S
    MUSICK, L
    WU, B
    KALDOR, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 120 - MEDI
  • [2] STRUCTURE-BASED DESIGN OF NOVEL NONPEPTIDIC HIV PROTEASE INHIBITORS
    LOVASZ, KD
    MORRIS, JK
    TOMICH, PK
    WATENPAUGH, KD
    HOWE, WJ
    DOLAK, LA
    ROMINES, KR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 25 - MEDI
  • [3] ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
    KALISH, V
    KALDOR, S
    SHETTY, B
    TATLOCK, J
    DAVIES, J
    HAMMOND, M
    DRESSMAN, B
    FRITZ, J
    APPELT, K
    REICH, S
    MUSICK, L
    WU, BW
    SU, K
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 : S201 - S214
  • [4] DISCOVERY OF A SERIES OF NONPEPTIDIC HIV PROTEASE INHIBITORS VIA STRUCTURE-BASED ITERATIVE DRUG DESIGN
    LEWIS, K
    MUSICK, L
    WU, BW
    ANDRADA, D
    SHETTY, B
    DAVIES, J
    REICH, S
    APPELT, K
    MELNICK, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 20 - MEDI
  • [5] STRUCTURE-BASED DESIGN OF NONPEPTIDIC HIV PROTEASE INHIBITORS FROM A CYCLOOCTYLPYRANONE LEAD STRUCTURE
    ROMINES, KR
    WATENPAUGH, KD
    HOWE, WJ
    TOMICH, PK
    LOVASZ, KD
    MORRIS, JK
    JANAKIRAMAN, MN
    LYNN, JC
    HORNG, MM
    CHONG, KT
    HINSHAW, RR
    DOLAK, LA
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (22) : 4463 - 4473
  • [6] Structure-based design of nonpeptidic HIV protease inhibitors: The sulfonamide-substituted cyclooctylpyranones
    Skulnick, HI
    Johnson, PD
    Aristoff, PA
    Morris, JK
    Lovasz, KD
    Howe, WJ
    Watenpaugh, KD
    Janakiraman, MN
    Anderson, DJ
    Reischer, RJ
    Schwartz, TM
    Banitt, LS
    Tomich, PK
    Lynn, JC
    Horng, MM
    Chong, KT
    Hinshaw, RR
    Dolak, LA
    Seest, EP
    Schwende, FJ
    Rush, BD
    Howard, GM
    Toth, LN
    Wilkinson, KR
    Kakuk, TJ
    Johnson, CW
    Cole, SL
    Zaya, RM
    Zipp, GL
    Possert, PL
    Dalga, RJ
    Zhong, WZ
    Williams, MG
    Romines, KR
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (07) : 1149 - 1164
  • [7] STRUCTURE-BASED DRUG DESIGN OF NONPEPTIDIC P-2 SUBSTITUENTS FOR HIV-1 PROTEASE INHIBITORS
    KALISH, VJ
    TATLOCK, JH
    DAVIES, JF
    KALDOR, SW
    DRESSMAN, BA
    REICH, S
    PINO, M
    NYUGEN, D
    APPELT, K
    MUSICK, L
    WU, BW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (07) : 727 - 732
  • [8] Structure-based drug design of HIV protease inhibitors.
    Navia, MA
    Tung, RD
    Chaturvedi, PR
    Rao, BG
    Partaledis, JA
    Kim, EE
    FASEB JOURNAL, 1996, 10 (06): : 2436 - 2436
  • [9] Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: Secondary amide series
    Reich, SH
    Melnick, M
    Pino, MJ
    Fuhry, MAM
    Trippe, AJ
    Appelt, K
    Davies, JF
    Wu, BW
    Musick, L
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (14) : 2781 - 2794
  • [10] Structure-based design of nonpeptidic inhibitors for the malarial protease plasmepsin II.
    Hof, F
    Schütz, A
    Bur, D
    Diederich, F
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U219 - U219
12345